False Negative Results Found in Prognostic Testing for Breast Cancer

A recent study evaluating HER2 testing in a large cohort of women with breast cancer found important limitations in the conventional way HER2 testing is performed in the U.S. and internationally.

Source: News at Dartmouth Medical School - June 20, 2014 Category: Hospital Management Authors: Donna Dubuc Tags: Press Release Research breast cancer HER2 Norris Cotton Cancer Center Peter Kaufman Source Type: news